MedTrace Logo

CovidSurg-3: Outcomes of Surgery in COVID-19 Infection

NCT05161299 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-12-17

No results posted yet for this study

Summary

COVID-19 has significant detrimental impacts on surgical systems and patient outcomes. CovidSurg has provided the best available evidence to guide delivery of safe surgery during the pandemic. However, CovidSurg data were collected in 2020 when the wildtype SARS-CoV-2 virus was dominant, and therefore there is a need to for renewed rapid data to guide global practice during Omicron COVID-19 waves.

CovidSurg-3 is an extension to CovidSurg and was initiated in response to the emergence of the Omicron variant.

CovidSurg-3 has two separate components:

* Patient-level component: Collection of outcome data for patients with peri-operative SARS-CoV-2.
* Hospital-level component: Collection of aggregated case-mix data. Hospitals in countries with low community SARS-CoV-2 infection rates can contribute towards this component.

Conditions

Interventions

PROCEDURE

Surgery (across all specialities)

Surgery performed by a surgeon in an operating theatre during the patient inclusion period

Sponsors & Collaborators

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Aneel Bhangu · University of Birmingham

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-13
Primary Completion
2022-02-28
Completion
2022-03-29

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05161299 on ClinicalTrials.gov